欢迎来到奈克斯特进出口贸易有限公司官方网站!!!

奈克斯特进出口贸易有限公司

News

联系方式

  • 电话:
    025-57921830
  • 邮箱:
    phoebe@nixmedical.com
  • 地址:
    南京市江北新区大厂街道新华村路188号5376室

News

当前位置:主页 > News >

Recently, China investment consulting network released "China medical device industry investment analysis and prospect forecast report 2017-2021", which mentioned the development of China's medical device industry three major factors, as well as the medical device market and revenue and profit stopped to forecast.
 
This article is reprinted in China investment consulting network, edited by yiou, for industry reference.
 
I. development elements
 
1. Policy progress
 
Under the background of the new medical reform, the coverage of the medical insurance system has been expanded, and the per capita funding and reimbursement ratio have been increased, which has played a positive role in promoting the development of medical devices. The policy supports the development of innovative medical device industry.
 
(2) large space for development
 
China's health service industry covers a wide range and has a long industrial chain, while medical devices, as the fundamental supporting industry of the health service industry, have great potential for development. Driven by national policy and market demand, China has become a huge consumer market for medical devices, and the medical device industry is developing rapidly. At the same time, in the context of the new medical reform, the system of "supplementing medicine with medicine" is being corrected, and medical services and medical devices will be further developed rapidly. Meanwhile, China's ratio of medical devices to drugs is less than 1:5, compared with 1:1 in the booming world. China's medical device industry has a broad space for growth. At present, China's medical device industry has initially established an industrial system with complete professional categories, complete industrial chain and strong industrial foundation, which has become the basic industry, leading industry and pillar industry of China's national economy.
 
(3) Internet plus
 
Pharmaceutical e-commerce has become a new blue ocean in the "Internet plus" era. The mobile Internet has shaped a brand new social lifestyle. The "Internet plus" action plan from time to time helps enterprises to carry out. The influence of the Internet on the pharmaceutical industry has entered a new stage. What deserves our special attention is that the current pharmaceutical e-commerce enterprises are no longer a pure commodity trading platform. Diversified channels, diversified products, diversified services and diversified forms have extended the tentacles of pharmaceutical e-commerce enterprises to the entire pharmaceutical industry chain and become the strength to promote the development of pharmaceutical e-commerce and even the whole pharmaceutical industry chain.
 
Second, sales revenue forecast
 
In 2014, the sales revenue of China's medical device and device manufacturing industry reached 213.6 billion yuan, a year-on-year growth of 13.01 percent. From January to September 2015, the sales revenue of China's medical device and device manufacturing industry reached 169.3 billion yuan, with a year-on-year growth of 11.6%. The ccic industry research center estimates that the sales revenue of China's medical device and device manufacturing industry will reach 282.9 billion yuan in 2017, with an average annual compound growth rate of 11.32% in the next five years (2017-2021), and the revenue in 2021 will reach 434.5 billion yuan.
 
Forecast of sales revenue of medical devices in the next five years
 
Profit forecast
 
In 2014, the total profit of China's medical device and device manufacturing industry reached 21.9 billion yuan, with a year-on-year growth of 10.05%. From January to September 2015, the total profit of China's medical device and device manufacturing industry reached 14.6 billion yuan, up by 7% year-on-year. The ccic industry research center estimates that the total profit of China's medical device and device manufacturing industry will reach 26.3 billion yuan in 2017, with an annual compound growth rate of about 8.05% in the next five years (2017-2021), and the annual revenue will reach 35.8 billion yuan in 2021.